Public Market Presence Panorama Capital went public in 2019 as a capital pool company and trades under the symbol PANO.P, signaling access to public markets and potential for equity-based collaboration, liquidity events, or co-investment opportunities.

Tech & Bio Focus The firm combines technology and life sciences investing, presenting opportunities to partner with portfolio companies across software, analytics, and biotech platforms that may require data infrastructure, cloud scalability, or pharmaceutical development support.

Growth & Co‑Invest Active funding activity includes a recent $45M Series C investment in NextWave Pharmaceuticals with co-leadership by Panorama Capital, indicating openness to syndication with other notable investors and potential for future co‑investment opportunities.

Lean Team, Broad Network With a small internal team but a high-profile investor posture, there is potential to provide outsourced fundraising, deal sourcing, or strategic advisory services to portfolio companies seeking to accelerate growth and attract additional capital.

Digital & Analytics Stack Current tech usage includes Windows Server, Azure, Google Analytics, and Microsoft ASP.NET, suggesting opportunities to offer cloud optimization, data analytics services, or security and compliance enhancements tailored to their portfolio and operations.